NCI Opens Up Phase III Trials
BETHESDA, Maryland-Oncologists nationwide now have access to National Cancer Institute (NCI) clinical trials under a new policy intended to encourage a wider participation in phase III studies. The new policy makes it easier for oncologists to become credentialed as investigators and to enroll their patients in the advanced studies through NCI’s Cancer Trials Support Unit (CTSU). Previously, access to NCI’s clinical trials was limited to members of NCI’s cooperative groups.
BETHESDA, MarylandOncologists nationwide now have access to National Cancer Institute (NCI) clinical trials under a new policy intended to encourage a wider participation in phase III studies. The new policy makes it easier for oncologists to become credentialed as investigators and to enroll their patients in the advanced studies through NCI’s Cancer Trials Support Unit (CTSU). Previously, access to NCI’s clinical trials was limited to members of NCI’s cooperative groups.
Oncologists can use the web-based CTSU to download protocols, case report forms, and other documents.
Interested physicians can enter the program through a two-phase application and credentialing process, which will include a site visit to ensure an oncologist’s capability to meet regulatory requirements and collect research data successfully. Information on the project is available online at www.ctsu.org, or by calling 1-888-823-5923.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
